Loading…
US stock · US markets · public data
ALNY
Alnylam Pharmaceuticals Inc · Healthcare
Reference price$255.96Updated according to the public source
P/E43.22
P/B25.28
ROE100.70%
DY 12M—
Net margin16.82%
Debt/equity2.21
Market capUS$ 34.3 B
Volume (shares)1,830,000
SectorHealthcare
Overview
Indicadores públicos consolidadosAbout ALNY
Alnylam Pharmaceuticals Inc (ALNY) is a stock traded in US markets in the Healthcare sector. P/E 43.22, P/B 25.28, ROE 100.70% and dividend yield not disclosed. The P/E multiple helps compare this asset's valuation with other companies in the same sector. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
Distributions
public dataDividends and distributions · last 12 records
The source returned no recent distributions for this asset.
Financials
No dataIncome statement, balance sheet and cash flow
Financial statements are not available for this asset yet.
FAQ
Frequently asked questions
What is the price of ALNY?
The current price of ALNY is $255.96.
What is the P/E of ALNY?
The P/E ratio of ALNY is 43.22, meaning investors pay 43.22 times earnings per share.
What is the P/B of ALNY?
The P/B of ALNY is 25.28, meaning the stock trades at 25.28 times its book value per share.
What is the ROE of ALNY?
The ROE (Return on Equity) of ALNY is 100.70%, meaning the company generates 100.70% of profit for every unit of shareholders' equity.
What is the market cap of ALNY?
The market capitalization of ALNY is US$ 34.3 B.
What is the net margin of ALNY?
The net profit margin of ALNY is 16.82%, meaning the company keeps 16.82% of revenue as profit.
What is the debt-to-equity ratio of ALNY?
The debt-to-equity ratio of ALNY is 2.21, meaning the company has 2.21 units of debt for each unit of equity.
What sector is ALNY in?
ALNY operates in the Healthcare sector.